title: Inappropriate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram.
authors.forename: D
authors.initials: D
authors.lastname: Zullino
authors.forename: S
authors.initials: S
authors.lastname: Brauchli
authors.forename: A
authors.initials: A
authors.lastname: Horvath
authors.forename: P
authors.initials: P
authors.lastname: Baumann
mesh_terms: D000855:Anorexia / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced; D003402:Creatine Kinase / Q000097:blood; D003865:Major Depressive Disorder / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D007527:Isoenzymes / Q000097:blood; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012206:Rhabdomyolysis / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012964:Sodium / Q000097:blood
chemical_list: D014150:Antipsychotic Agents; D002749:Chlorprothixene; D015283:Citalopram; D003402:Creatine Kinase; D007527:Isoenzymes; D011188:Potassium; D017367:Selective Serotonin Reuptake Inhibitors; D012964:Sodium